Skip to main navigation

Investors + Newsroom
Culture + Careers

Who We Are

Who We Are
Science & Innovation

Science & Innovation
Therapeutic Pipeline

Therapeutic Pipeline
Patients & Families

Patients & Families

Search
Investors + Newsroom
Culture + Careers

Biography

Overview
News
Events + Presentations
Stock Information
- Analyst Coverage
Sec Filings
Corporate Governance
Shareholder Services

Greg Ciongoli

Director

Member of the Nominating and Corporate Governance Committee
Member of the Audit Committee

Contact Us

Stay connected on REGENXBIO programs and our commitment to patients.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.

Contact Us

Terms and Conditions

Privacy Policy

© 2026 Regenxbio Inc. • "NAV®" is a registered trademark of REGENXBIO Inc. • All Rights Reserved